Lnc-C11orf16-1:1

Please input one-sentence summary here.

Annotated Information

Transcriptomic Nomeclature

Please input transcriptomic nomeclature information here.

Function

Please input function information here.

Regulation

Please input regulation information here.

Expression

Please input expression information here.

Allelic Information and Variation

Please input allelic information and variation information here.

Evolution

Please input evolution information here.

You can also add sub-section(s) at will.

Labs working on this lncRNA

Please input related labs here.

References

Please input cited references here.

Basic Information

Transcript ID	lnc-C11orf16-1:1
Source	LNCipedia2.1
Same with	,
Classification	intronic(S)
Length	131 nt
Genomic location	chr11-:8960581..8960712
Exon number	1
Exons	8960581..8960712
Genome context
Sequence	000001 CTAACTAGAC GCTATTGCTT GTTGAAGGCT TTGATCTTAG GAGGATTAGA AAGCATTCTA GGCCAGGCAC GGTGGCTTCC 000080 000081 TGTGTGTAAT CCCAGCAGTT GGAGAGGCTG AGGCAGGCGG GTTGCTTGAG C

[back to top]

Annotation (From lncRNAdb)

[lnc-C11orf16-1:1]

Section	Description
ID	NDM29
Characteristics	~130 nt. 'Alu-like RNA', it has a canonical Alu/7SL-derived sequence structure. Transcribed by RNA Polymerase III from the first intron of the ASCL3 (Achaete Scute-Like homologue 3) gene (Castelnuovo (2010)).
Expression	NDM29 expression was analyzed in 6 different cell types and found in abundant levels in neural cells (neuroblastoma cell lines SHSY5Y and SKNBE2, and primary culture of human glioma cells), but at a very low levels in epithelial-derived cells (HeLa, HEK293, and primary cultures of skin fibrobroblast). NDM29 expression was increased in differentiating cells (Castelnuovo (2010)). NDM29 RNA was detected in both the nucleus and cytoplasm of SKNBE2 and HeLa cells, but enriched (~70%) in the latter (Castelnuovo (2010)).
Function	In humans, NDM29 maps in a genomic region whose deletion has been shown to be involved in neuroblastoma development (De Preter (2005)). In-vitro over-expression of NDM29 promoted differentiation of neuroblastoma (NB) cells into cells with neuron-like features (including marker expression, morphology, anchorage-dependent growth and excitatory properties), and a reduction in the tumor initiating ('stem-like') cell fraction in the NB cell population. In-vitro and in-vivo experiments indicated that increased expression of NDM29 restricts NB development and malignancy. It also lead to reduced expression of multidrug resistance 1 (MDR1) mRNA in malignant NB cells, and so increased their susceptibility to doxorubicin and cis-platinum antiblastic drugs used in NB therapy (Castelnuovo (2010)).
Conservation	RNA was detected in humans - Alu-derived elements are restricted to primate lineage (Castelnuovo (2010)).
Misc	NDM29 transcript comprises Alu sequences and unique sequences and might have been inserted into the genomic locus by retrotransposition (Castelnuovo (2010)). Similar to 21A RNA, it is also a short interspersed nucleotide element, marked as AluJb elements. (Pagano (2007))
Name	NDM29: neuroblastoma differentiation marker 29 (Castelnuovo (2010), Pagano (2007)).

[back to top]